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Background. Probes that allow site-specific protein labeling have become critical tools for visualizing biological processes.
Methods. Here we used phage display to identify a novel peptide sequence with nanomolar affinity for near infrared (NIR)
(benz)indolium fluorochromes. The developed peptide sequence (‘‘IQ-tag’’) allows detection of NIR dyes in a wide range of
assays including ELISA, flow cytometry, high throughput screens, microscopy, and optical in vivo imaging. Significance. The
described method is expected to have broad utility in numerous applications, namely site-specific protein imaging, target
identification, cell tracking, and drug development.
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INTRODUCTION
A number of advances in reporter and imaging technologies have
led to the widespread use of fluorescent proteins (FP) and site-
specific binders. Fusions of fluorescent proteins (e.g. green (GFP)
or red fluorescent proteins (RFP)) and target proteins of interest
have been used to study diverse cellular processes such as mitosis,
DNA repair, cytoskeletal remodeling, receptor trafficking, focal
adhesion, local calcium concentrations, membrane potential, pH,
and microbial pathogenesis[1–3]. While such fusions demonstrate
precise one-to-one targeting, they are constrained by the stability,
fluorescence, and sensor properties of the mutant GFP, thus, their
broader applicability as nanoscale indicators have some practical
limitations. In addition, steric hindrance of FP in proximity to its
target can potentially disrupt the native interactions of nearby
proteins in multimeric complexes or alter cellular localization[4,5].
An alternative to fluorescent fusion proteins is the use of site-
specific small molecule labeling strategies. Recently developed
methods have employed specific peptide handles to recruit small
molecule ligands[6,7], harnessed enzyme activity to catalyze
conjugation of tags[8,9], or made use of cellular protein
machinery[10,11]. Some of these methods are particularly useful
for in vivo imaging in whole organisms[8]. Higher affinity,
increased target-to-background ratios and one-step reactions that
do not rely on exogenous enzymes[12,13] would further enhance
the utility of these approaches.
Organic fluorochromes are intriguing molecular probes, as they
do not suffer from many of the detrimental aspects of FP. These
dyes have played an essential role in immunofluorescence,
analytical testing, and other emerging imaging applications. In
particular, far red (FR) and near infrared (NIR) fluorochromes
containing (benz)indolium subunits have proven useful in
a multitude of in vivo imaging applications, as light penetrates
tissue more efficiently and because tissue autofluorescence is much
lower in this range[14,15]. To expand the utility of these
fluorochromes, it would be useful to develop biological ligands
tailored specifically to the structure of the dye, ideally with affinity
constants surpassing those of monoclonal antibodies. Thus, the
discovery of short peptides specific to organic fluorochromes
through library screening may a) provide a minimally invasive way
of ‘‘tagging’’ proteins, b) enable imaging of intracellular proteins
and c) provide specificity since endogenous proteins should not
recognize NIR dyes.
In the current study we use phage display screening to
determine whether peptides with sufficiently high affinity for
(benz)indolium-derived fluorochromes could be identified. We
found that screening a 7-mer library results in convergence onto
a single peptide sequence with subnanomolar affinity for these
dyes. Furthermore, the utility of the peptide for analytical testing,
cell labeling, and in vivo imaging is demonstrated. The developed
peptide sequence should be broadly applicable in a variety of
analytical and imaging applications (Fig. 1).
RESULTS
Utilizing a linear, random 7 amino acid phage display library to
first select against a model (benz)indolium fluorochrome (GH680),
we observed .100-fold enrichment in the third and fourth rounds
of panning, suggestive of a successful selection (Fig. 2A). Moreover,
identification and alignment of amino acid sequences of individual
clones from rounds 2, 3, and 4 revealed a robust enrichment and
narrowing to a small area of the peptide diversity space. Alignment
of the sequences from round 2 showed lack of a single consensus
family, however by the third and fourth round, one had emerged
(Fig. 2B). In the fourth round, 63% (19/30) of the peptides
contained the sequence IQSPHFF (IQ-tag). Although round two
did not have a clear consensus, the IQSPHFF sequence was
indeed present. In addition to the IQSPHFF peptide, a second
although less prevalent (20%; 6/30) motif consisting of HHS/
HHXH was also identified through the selection (Fig. 2B).
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(benz)indolium fluorochromes (Cy3.5, Cy5.5, GH680, and Alexa
Fluor 750 (AF750)) was determined. Fig. 3A illustrates the binding
affinity of each dye for the IQ peptide on phage, with GH680
exhibiting the highest affinity. This binding affinity was trailed
closely by AF750, whereas Cy3.5 and Cy5.5 both exhibited
approximately four-fold less binding than GH680. To better
understand the differences in affinity, we performed molecular
modeling, assuming that the fluorochromes were relatively rigid
active sites to which the peptide ‘‘ligand’’ was bound. In compar-
ing the resulting structures, several putative binding interactions
became apparent (Fig. 3B–D). The C-terminus of the peptide,
containing the hydrophobic and aromatic phenylalanine residue,
interacted with one of the (benz)indolium subunits via p-p
interactions (Fig. 3B). The next three amino acids, SPH, extended
over the alkene linker of the cyanine dyes to the opposite face of
the fluorochrome, with the hydrophilic portions directed away
from the core (Fig. 3C). Lastly, the hydrophobic N-terminal
isoleucine interacted with the similarly hydrophobic alkene linker
(Fig. 3D). In the case of Cy 3.5, this last interaction was not
observed, which is most likely due to the length of the linker and
steric strain (the length of the linker in Cy 3.5 is 3 carbons, in Cy
5.5 and GH680 is 5 carbons, and in AF750 is 7 carbons; Fig. S1).
Similar to Cy 3.5, the interaction between the peptide and Cy 5.5
is lessened by a sub-optimal interaction of the isoleucine with the
flexible hexanoic acid moiety used in the conjugation of the
fluorochrome (Fig. S1B). For GH680 (Fig. 3B–D) all three
interactions were viewed as optimal.
The dependence on context of IQ-tag binding to GH680 was
characterized next. First, we determined the affinity of IQ-tag
displayed on phage to immobilized GH680-BSA. The binding
curves formed a classic sigmoidal shape indicative of specific
binding of the dye to IQ-tag with an average KD of 0.536
0.2 nmol/L. To elucidate whether this binding was specifically
due to the presentation of IQ-tag on the phage (Fig. 4A), we
cloned the sequence encoding this peptide on the p7 coat proteins
located on the opposite end of the phage. Phage expressing N9-p7-
AIQSPHFF likewise demonstrated a sigmoidal dose response
(r
2=0.984) with high affinity (Kd 0.5360.12 nmol/L). In contrast,
phage without displayed peptides demonstrated negligible binding.
To estimate the stoichiometry of the dye binding to phage
displaying IQ-tag, a known concentration of phage was incubated
with the dye. This resulted in approximately one fluorochrome per
peptide (7.462.0, SD).
To further investigate the molecular interactions of IQ-tag with
NIR fluorochromes, we applied dilutions of GH680 to chemically
coated glass slides and used them in colorimetric immunoassays
(Fig. 4B). The (benz)indolium dye spotted glass slides were
incubated with IQ-tag displaying phage and the binding was
detected with anti-M13-HRP. Under these conditions, concentra-
tion dependent binding of the targeted phage to GH680 was
observed. In this application, the peptide had a half-maximal
Figure 1. Bioapplications of the IQ-tag-benzindolium fluorochrome binding pair.
doi:10.1371/journal.pone.0000665.g001
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(Fig. 4B). GH680 was next immobilized on polystyrene microbeads
and was interrogated with fluorescein (FITC) labeled IQ-tag
displaying phage. Fluorescence microscopy showed strong binding
of phage to the dye-modified beads (Fig. 4C), but not to unmodified
control beads (Figure 4D) (p,10
236, t-test). These data further
suggestthattheIQ-tagmotifspecificallybindsto(benz)indoliumdye,
itself, and is not dependent on the presence of BSA.
The high affinity observed in phage is not always correlated
with the same affinity in the monomeric and free form of the
peptide due to avidity effects as a result of multiple copies of the
peptide on the phage surface. Therefore, we synthesized soluble,
free monomeric peptide corresponding to the sequence
IQSPHFFGGSK(biotin) (IQ-tag) and asked whether the peptide
could probe GH680 modified polystyrene beads. Flow cytometry
results depicted in Figure 5A demonstrate that this is indeed
possible. To further corroborate this result and to demonstrate the
strength of the interaction, we asked whether IQ-tag -NIR
complexes could form and co-elute utilizing C18 reverse phase
HPLC. Free NIRF eluted immediately after the void volume of the
column. In contrast, when peptide and NIRF were incubated then
injected, the peak corresponding to fluorochrome shifted and was
retained longer, indicating the binding of fluorochrome to peptide
(Figure S2). Surface plasmon resonance analysis showed a satura-
ble, dose-dependent response with an affinity of the monomeric
peptide binding to GH680 of approximately ,100 nmol/L
(Fig 5B). We next examined the NIRF fluorescence shift and
relative quantum yield upon binding (Fig 5C and 5D). Binding of
IQ-tag to GH680 blue shifted the absorption by 14 nm and
increased the relative quantum yield from 0.89 to 1, a 12%
increase.
To determine whether IQ-tag may be useful for imaging cells,
we first conjugated the N-hydroxysuccinimide ester functionalized
peptide sequence (IQ-tag-NHS) onto HT1080 colon adenocarci-
noma cells and incubated cells with 1 nmol of GH680 (Fig. 6A).
Peptide labeled cells bound fluorochrome greater than 120 fold
better than unlabeled cells. In addition, free unconjugated peptide
was able to compete for 98% of the bound dye (Fig. 6A). A
bicistronic construct expressing dsRed and a fusion protein with
IQ-tag fused to the amino terminus of the platelet-derived growth
factor receptor (PDGFR) transmembrane domain was subse-
quently created to directly image protein expression and tumor
cells. Transfection and expression of the peptide was confirmed by
the co-expression of dsRed. HEK-293T cells that were expressing
dsRed, also bound benzindolium fluorochrome (Fig. 6B). GH680
did not bind to cells devoid of dsRed expression. In addition, cells
were found to bind GH680 in the plasma membrane, as visualized
by confocal microscopy (Fig. 6C). This construct was further
extended for in vivo visualization and tracking of cells and the
PDGFR protein. Biodistribution experiments show that GH680
was rapidly eliminated via renal excretion with lung, muscle, and
liver fluorescence minimal within 4 hours after injection (Fig. 6D).
Importantly there was no non-specific binding to muscle tissue
where titin (a protein with the nearest sequence to IQ-tag) is
expressed abundantly. To determine whether we could image cells
in vivo using this system, IQ-tag expressing cells were first
Figure 2. Phage display selection and evolution of IQ-tag phage. A. Fold enrichment of NIR fluorochrome (BSA-GH680)-selected phage. B.
Sequences of randomly selected phage clones isolated from biopanning rounds 2, 3, and 4. Note appearance of two families containing (Q)SP/TP and
HXHH, and expansion of clone IQSPHFF.
doi:10.1371/journal.pone.0000665.g002
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injection of GH680 and imaging by fluorescence mediated tomo-
graphy (FMT) (Fig. 6E). After intravenously injecting GH680, IQ-
tag expressing cells became brightly fluorescent with the signal
persisting for over 24 hours whereas contralaterally implanted
control cells showed negligible fluorescence (42.2 nM vs 1 nM in
control leg; p,0.0001).
DISCUSSION
A number of reporter and imaging technologies have recently been
developed to visualize site-specific proteins and cellular trafficking
(reviewed in[2,13]). Specific examples include protein tags, such as
tetracysteine or hexahistidine motifs, which are recognized by bi-
arsenic-derivitized fluorescein[16], his-tags for Ni-NTA-conjugated
fluorochromes[17], or various forms of biotin ligases that are
revealed with labeled avidins[3,8]. Collectively, these methods have
allowedunprecedented insight intocellular protein trafficking.Based
on the hypothesis that it is feasible to develop affinity ligands to
commercially available (benz)indolium fluorochromes that are
commonly utilized in vivo, we performed de novo phage screens
for high affinity binding peptides. Here we report on a novel peptide
tag forNIR dyes,whichisshort,linear,anddoesnot occurinnature.
TheidentifiedIQ-tagpeptide(IQSPHFF)isuniqueandhasasub-
nanomolar binding affinity for the NIR fluorochrome GH680, due
toa number of optimal binding interactionsbetweenthe peptideand
benzindolium dye. According to results obtained from molecular
modeling studies of the docked ligand, p-stacking between the
phenylalanine residues of IQ-tag and the (benz)indolium subunit of
the fluorophore yields preferential orientation of the peptide on the
dye. The next three amino acids, SPH, extend over the alkene linker
of the dye to the opposite face with the hydrophilic portions directed
away from the core. Finally, the hydrophobic N-terminal isoleucine
is able to interact with the similarly hydrophobic polymethine linker.
When the binding of the peptide to various other cyanine dyes
(AF750, Cy5.5, Cy3.5) is investigated, varied affinity constants are
obtained. These differences in affinity, as well as alterations to the
peptide sequence, could be used to identify IQ-tag like sequences
with even higher affinity or subsets with affinity for specific NIR
fluorochromes. For example, the use of unnatural amino acids or
additional screens with mRNA display[18] could be used to yield
additionally evolved compounds. The somewhat hydrophobic IQ-
tag can also be modified at either its N- or C-terminus in order to
modulate the polarity of the peptide.
In order to determine whether the IQ-tag peptide has homology
to any sequence naturally occurring in the mammalian genome,
a Basic Local Alignment Search Tool (BLAST) search of the
human and mouse proteomes was conducted. Five out of the seven
amino acids were found to match a sequence within titin, a giant
polypeptide found in striated muscle cells. Molecular modeling of
the titin peptide on GH680 failed to demonstrate the same binding
mode as the IQ-tag peptide, intimating the importance of the
serine and two terminal phenylalanine residues. Therefore, it is
unlikely that this sequence will exhibit as exquisite an affinity for
benzindolium fluorochromes as the 7-mer IQ-tag. Thus, few
restrictions may exist for biological applications of the IQ-tag/NIR
fluorochrome interaction.
The dye sensing ability of the IQ-tag system is amenable to
a number of different modalities (Fig. 1). For example, we envision
Figure 3. Molecular modeling of IQ-tag binding to benzindolium fluorochrome. A. Binding of IQSPHFF phage to BSA-conjugated fluorochromes
via ELISA. B. p-stacking between the phenylalanines of the peptide and the benzidolium subunit of GH680 C. SPH amino acids extend over the linker
of GH680 to the opposite face of the fluorochrome D. Interaction of the hydrophobic isoleucine residue and the polymethine linker of the
fluorochrome.
doi:10.1371/journal.pone.0000665.g003
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peptide fused to cytoplasmic proteins, expression of the peptide on
prokaryotic cells, multivalent display of IQ-tag on a variety of
nanomaterials and sensors, site-specific protein expression, and
eukaryotic cell tagging applications. Furthermore, the IQ-tag
sequence, modified with a non-cyanine dye-based fluorochrome,
radioisotope, or biotin, could also be used as an amplification
strategy to determine (benz)indolium fluorochrome localization
and/or concentration. Another possibility, as shown in our cell
experiments, is the inclusion of this sequence as a handle on an
engineered protein to permit in vitro or in vivo protein or cellular
imaging. If the tagged protein is an internalizable receptor, growth
factor, viral coat protein, or peptide toxin, an avenue for detailed
and live imaging of intracellular receptor or drug trafficking
becomes plausible. The described IQ-tag technology is anticipated
to be particularly useful for in vivo experimentation, as the
transparency of animal tissue increases at far-red and near-
infrared wavelengths. In total, IQ-tag represents a system, which is
expected to have immediate, broad biological application.
MATERIALS AND METHODS
Materials
Cy3.5 and Cy5.5 were obtained from GE Healthcare (Niskayuna,
NY). Alexa Fluor 750 was obtained from Invitrogen (Carlsbad,
CA). Genhance 680 (GH680) was obtained from VisEn Medical
(Woburn, MA). Polystyrene particles were obtained from Bang’s
Laboratories, Inc (Fishers, IN). Amino functionalized slides were
from Sigma. All molecular biology and cloning reagents were from
New England Biolabs (Beverly, MA), except Omnimax T2
Ultracompetent Bacteria (for transformation and RFDNA pre-
parations) and custom oligonucleotide primers, which were from
Invitrogen. Rapid DNA Ligation Kits, which were obtained from
Roche (Indianapolis, IN). All other chemicals were from Fisher
Scientific or Sigma-Aldrich.
Phage selection
We used a phage library that expresses random 7-amino acid
sequences on the N-termini of all 5 p3 coat proteins. For selection,
we covalently coupled GH680 to BSA and immobilized the
conjugate on Nunc Maxisorp plates (Fisher). In addition, we
prepared a subtraction well containing a BSA-only sample. After
a subtraction step designed to filter BSA-and/or plastic-binding
clones from subsequent pans, four successive rounds of binding,
elution, and amplification were performed.
Phage ELISA
NHS ester of GH680, Cy3.5, Cy5.5 or AF750 (1 mg) was
conjugated to BSA (100 mg/mL BSA, 0.3M NaCO3 buffer, pH
Figure 4. IQ-tag binds with high affinity to GH680 and permits imaging via fluorescence microscopy and FACs. A. Representative sigmoidal dose
response curve of IQ-tag binding to the benzindolium fluorochrome (KD=0.5360.12 SD). Bars, SEM. B. Immunodetection of GH680 on a glass slide via
IQ-tag phage and anti-M13. Integrated pixel density of TMB substrate deposition via anti-M13-HRP reactions on spot dilutions of GH680. C. beads
conjugated to GH680 or D beads conjugated to BSA were incubated with IQ-tag displaying FITC labeled phage and imaged via fluorescence
microscopy (20x objective, equal exposure, FITC channel). Insets: Pixel topography renditions of the images from C and D. Average fold FITC intensity
comparing dye-conjugated and unconjugated beads is 6.1 (p,10
236, t-test).
doi:10.1371/journal.pone.0000665.g004
Imaging with Peptide/NIRF Pair
PLoS ONE | www.plosone.org 5 July 2007 | Issue 7 | e6658.6, 1hour 37uC) under reaction conditions of approximately
tenfold molar excess fluorochrome to BSA. BSA-fluorochrome
conjugate or BSA was adsorbed (5.0 mg/0.1 ml per well) overnight
to wells of a Nunc Maxisorp plate (Nunc, Rochester, NY).
Supernatants were discarded and blocked (5% BSA, 0.3M
NaCO3, pH 8.6, RT, 45 min). After two washes (PBS), 1:2 serial
dilutions of phage (,10
11 to ,10
9 PFU/well) in DPBS+1% BSA
were added to wells and incubated for 1 hour. Subsequent to
incubation, wells were washed (56PBS+0.05% Tween-20) and
incubated (1:5,000, DPBS+1% BSA) with anti-M13 conjugated to
HRP (GE Biosciences, Piscataway, NJ) for 45 min. Next, wells
were washed again (56PBS+0.05% Tween-20) and developed
with tetramethylbenzidine (TMB), and absorbance at 650 nm was
determined (Emax, Molecular Devices, Sunnyvale, CA). Mean
difference between absorbances in the BSA-Fluorochrome con-
taining wells and the BSA-only wells were calculated. EC50 values
were obtained using sigmoidal dose response (variable slope) curve
fitting from Prism 4 (GraphPad Software, San Diego, CA).
Cloning
To generate IQSPHFF peptide fused to the N-terminus of g7
splice overlap extension PCR was performed using M13KE
RFDNA according to manufacturer’s instructions (New England
Biolabs, Beverly, MA). p7-IQSPHFF-containing phage clones
were positively screened by mobility shift in PCR and confirmed
by DNA sequencing.
Fluorescence Microscopy
Polystyrene beads conjugated to NHS-GH680 (NaHCO3 buffer,
pH 8.6) or unconjugated control beads, were blocked with 5%
BSA, washed, and incubated with FITC-labeled IQSPHFF phage.
Following incubation, beads were washed 5x, and supernatants
were discarded. Beads were then dissolved to approximately 5,000
per mL, plated in a 96-well plate, and viewed by fluorescence
microscopy using the 206 objective (Axiovert 100 TV, Zeus,
Thornwood, NY). To obtain quantifiable fluorescence data from
microscopic images, randomly selected bead images were analyzed
for integrated pixel density (IPD) via Image J software.
Colorimetric Coated Slide Assay
Serial dilutions of GH680 were spotted on an amino functionalized
glass slide (Sigma-Aldrich) and were incubated overnight (4 uC),
allowed to air dry, and then blocked with 5% BSA (0.3M NaCO3,
pH 8.6) for 1 hr, RT with gentle agitation. Following this, the slide
wasrinsedwithDPBSandincubatedwith10
12PFUofIQ-tagphage
suspended in DPBS for 2-3 hrs. Supernatants were discarded and
the slide was washed (365 min.) with DPBS plus 0.05% Tween-20.
Next, anti-M13-HRP was added to the slide (1:5,000+5% BSA in
Figure 5. Characterization of IQ-tag peptide/GH680 interaction. A. IQ-tag-Biotin peptide was incubated with NIR fluorochrome-conjugated Bang’s
beads (red histogram) or BSA conjugated Bang’s beads (black histogram), then incubated with streptavidin-FITC and analyzed via flow cytometry. B.
BiaCore experiments. IQ-tag-biotin was immobilized on a streptavidin chip then decreasing concentrations of GH680 were flowed over the surface
(640 nM to 40 nM, bottom line buffer only control). C and D. Photochemical properties of GH680 (green trace) and GH680+IQ-tag (red trace). GH-680
binding to IQ-tag blue shifts the absorption by 14 nm.
doi:10.1371/journal.pone.0000665.g005
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Following 4 washes (DPBS+0.05% Tween-20; final wash dH20), the
slide was developed with TMB. Images of the slide were captured
with a digital camera (Nikon CoolPix).
Flow Cytometry
To verify binding of free biotinylated, IQ-tag peptide to GH680
via FACS, 10
6 polystyrene Bangs beads per reaction were labeled
with GH680 (10
10 fluorochromes per bead, 0.1 nmol per mL in
160 mL 0.3 M NaCO3, pH 8.6 1h RT), washed (3x), blocked (5%
BSA, 0.3M NaCO3, pH 8.6, 1 hr.), resuspended in binding buffer
(100 mL DPBS+0.05% Tween 20+1% BSA) containing 1mg of
IQSPHFF peptide (+/2), washed (36 500 mL DPBS+0.05%
Tween 20), probed with FITC-Streptavidin (1hr. at RT X 1:200 in
DPBS+0.05% Tween 20+1% BSA), resuspended in DPBS, and
analyzed via FACS.
Molecular Modeling and Peptide Characterization
All molecular modeling, minimization, and docking were
accomplished in Cache 6.1 (Fujitsu, Tokyo, Japan). The ground
state geometry of the peptide (IQSPHFF) and each fluorochrome
was calculated using CONFLEX/MM3 (medium search) param-
eters. The peptide was docked onto the fluorochrome using the
dye as a rigid active site, while the peptide was identified as the
flexible ligand. Once docked, the geometry was further optimized
using the CAChe FastDock algorithm. All experiments were
performed in triplicate to ensure consensus of the binding motif.
For spectroscopic experiments, the fluorescence emission spectrum
of GH680 or GH680/IQ Tag (ratio of 1:1) in distilled water was
obtained and the integrated area under the curve (AUC)
calculated. The relative fluorescence quantum yields were
calculated from the ratio of the AUC of the two solutions. All
measurements were performed in triplicate. For surface plasmon
resonance experiments, biotinylated peptide was captured onto an
avidin/dextran surface followed by injection (640 to 40 nM) then
continuous flow of GH680 over both control and active surfaces
(BiaCore, GE, Cambridge, MA).
Synthesis of IQSPHFFGGSK peptide
IQSPHFFGGSK(biotin) IQ-tag peptide was purchased from Tufts
Peptide Core Facility and used as received. To produce the N
Figure 6. Peptide-NIR dye pair allows for the in vitro and in vivo detection of cells. A. Vehicle treated and IQ-tag modified HT1080 cells were
incubated with GH680. The presence of the (benz)indolium fluorochrome was detected via a fluorescence plate reader. B. HEK-293T cells with the
expression of dsRed and IQ-tag peptide fused to PDGFR were imaged via fluorescence microscopy for their ability to bind GH680. C. Confocal
microscopy showing membrane localization of GH680. Scale bars: 10 mm D. Non-IQ-tag animals were injected tail vein with GH680 and organs
removed at indicated time points post injection to quantify fluorochrome concentrations. E. Mice implanted with HEK-293T cells expressing IQ-tag
peptide fused to PDGFR (right flank) or without expression (left flank) were injected with GH680 then imaged via FMT.
doi:10.1371/journal.pone.0000665.g006
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K(ivDde)G-Su was synthesized on an automated solid phase
peptide synthesizer (433A, Applied Biosystem, Foster City, CA)
employing the traditional Fmoc methodology on Fmoc-Gly-Wang
Resin (154 mg, 0.1 mmol). Upon completion of the synthesis, the
peptide-resin in DMF (4 mL) was acetylated using acetic
anhydride (30 mL, 3.3mmol) and diisopropylethylamine (DIPEA,
40 mL, 3.8 mmol). The reaction proceeded for 30 min, at which
point the resin was washed twice with DMF and reacted a second
time using the conditions listed above. The resulting acetylated
peptide resin was cleaved from the resin using 95% TFA/2.5%
triisopropylsilane (TIS)/2.5% H2O for 2 h, filtered to remove the
resin, and precipitated in methyl-tert-butyl ether (MTBE). The
precipitate was dissolved in DMF (4 mL), and reacted with N-
hydroxysuccinimide (NHS, 58 mg, 0.5 mmol), dicyclohexylcarbo-
diimide (DCC, 103 mg, 0.5 mmol), and dimethylaminopyridine
(DMAP, 61 mg, 0.5 mmol) for 1 h. The solution was filtered
through cotton wool to remove dicyclohexylurea, and precipitated
with MTBE (10 mL) to yield the crude product. The crude
product was then purified via HPLC then subjected to mass




HT1080 cells (20,000 cells/well) were washed 3x with PBS to
remove media then incubated with 0.1 mL of 100 mM of Ac-
IQSPHFF-NHS peptide (IQ-tag-NHS) or vehicle (PBS with 1%
DMSO) for 1 hour at 37uC. The NHS functional group will
covalently conjugate the peptide onto proteins with free amine
groups on the cells. Subsequent to incubation, cells were washed
then incubated for 1 hour at 37uC in the dark with 1 nmole of
GH680 or 1 nmole of GH680+5 nmoles of underivatized peptide
(competition experiment). Cells were then washed 6x with
PBS+0.1 % Tween 20 and analyzed via fluorescence plate reader
GeminiXS (Molecular Devices).
Vector DNA containing bicistronic mammalian expression
cassettes encoding ds-Red and a PDGFR transmembrane domain
chimera that exposes the IQSPHFF peptide were transfected
accordingly. For confocal microscopy imaging of HEK-293T cells,
100,000 cells per well of a 4-well chamber slide (Nunc, Rochester,
NY) were plated then transfected 16hrs later using Lipofecta-
mine2000 reagent at a concentration of 1.2 mg DNA and 2 mlo f
Lipofectamine per well, according to manufacturer’s instruc-
tions. 68h after transfection, wells were washed gently with DPBS
and replaced with 200 ml of DPBS containing 50 mmol/L GH680
680 and 1%BSA for 1h at 37C. Treated wells were then washed
(3x DPBS+1% BSA+0.01% Tween-20), fixed (5–10 min.6
DPBS+2 % paraformaldehyde), then imaged via the 20x objective
of the Nikon Axiovert-100 inverted microscope and IPLab
software and via the 40x objective of a Zeiss LSM Pascal confocal
microscope (Carl Zeiss, Thornwood, NY).
In Vivo Imaging
For in vivo imaging of HEK-293T cells, 5 million cells were
transfected into twin wells of a 6-well plate with parameters scaled
to those described above. IQ-tag-PDGFR transfected and mock
transfected cells were injected locally for imaging and then probed
via systemic injection of GH680 (2 nmoles). Imaging was
performed by fluorescence mediated tomography (FMT). Mice
were anesthetized by inhalation anesthesia (2% isoflurane, 1 L/
min O2) using an isoflurane vaporizer (Braintree Scientific,
Braintree, MA). FMT experiments were performed using
a commercially available imaging system (VisEn Medical,
Woburn, MA). Data sets were acquired at wavelengths 680/
700 nm excitation/emission in anesthetized mice. Image data sets
were reconstructed using a normalized Born forward model
adapted to small mouse models[19]. Image acquisition time per
animal was 2 minutes and reconstruction time was 1–2 minutes.
Images were displayed as raw data sets (excitation, emission,
masks) and as reconstructed 3D data sets in axial, sagital and
coronal planes. Fluorochrome concentration in the target was
automatically calculated from reconstructed images and expressed
as pmol fluorochrome/defined target volume. Biodistribution
experiments were conducted after systemic administration of
GH680 (2 nmoles) by removing organ samples and measuring
fluorochrome concentrations at different time points.
SUPPORTING INFORMATION
Figure S1 Molecular modeling of IQ-tag peptide binding to
representative fluorochromes. A. sub-optimal IQSPHFF docking
with Cy 3.5 (3-carbon linker too short). B. sub-optimal IQSPHFF
docking with Cy 5.5 (isoleucine-hexanoic acid interference). C.
IQSPHFF docking with AF750.
Found at: doi:10.1371/journal.pone.0000665.s001 (0.21 MB TIF)
Figure S2 Analysis of IQSPHFF peptide binding to NIRF via
HPLC. Free GH680 (upper trace) or GH680 incubated with IQ-
tag (lower trace) were analyzed via HPLC with a reverse phase
C18 column. Note the shift in retention time for NIRF incubated
with peptide indicating the formation of a stable complex.
Found at: doi:10.1371/journal.pone.0000665.s002 (0.11 MB TIF)
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